SAR566658
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SAR566658, covering 2017-05-10 to 2021-09-08. Get the full timeline:
Most recent: Clinical Trial Update: Study Evaluating Efficacy and Safety of SAR566658 Treatment in Patients With CA6 Positive Metastatic Triple Negative Breast Cancer [Phase 2]